Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28073987)
Watch
English
PCSK9 inhibitors - mechanisms of action
scientific article
In more languages
edit
Statements
instance of
scholarly article
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
review article
1 reference
stated in
Europe PubMed Central
title
PCSK9 inhibitors - mechanisms of action
(English)
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
author
Gerald Watts
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
author name string
Michael M Page
series ordinal
1
2 references
stated in
Crossref
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
language of work or name
English
1 reference
stated in
PubMed
publication date
1 October 2016
1 reference
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
published in
Australian Prescriber
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
volume
39
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
issue
5
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
page(s)
164-167
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
cites work
Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
20 March 2017
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
20 March 2017
The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
20 March 2017
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
20 March 2017
Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
20 March 2017
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
7 April 2017
A receptor-mediated pathway for cholesterol homeostasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
7 April 2017
Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
29 September 2017
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
29 September 2017
Sorting an LDL receptor with bound PCSK9 to intracellular degradation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
29 September 2017
Lipoprotein(a) as a therapeutic target in cardiovascular disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
29 September 2017
Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
29 September 2017
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
27 November 2018
Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5079795
retrieved
27 November 2018
Identifiers
DOI
10.18773/AUSTPRESCR.2016.060
1 reference
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
Fatcat ID
release_i42rwihqarfjrddbhih7ynnhma
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/i42rwihqarfjrddbhih7ynnhma
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PMCID
5079795
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
PubMed ID
27789927
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMCID
5079795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27789927%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
